# RedLeaf Biologics, Inc.: Form D filings

RedLeaf Biologics, Inc., a biotechnology company in Lexington, KY, filed 4 Form D notices with the SEC between 2016 and 2019. The latest, on November 7, 2019, reports $750,000 sold of a $750,000 offering to 2 investors.

Find out what RedLeaf Biologics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RedLeaf%20Biologics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RedLeaf%20Biologics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fredleaf-biologics-inc-1677182)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RedLeaf%20Biologics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RedLeaf%20Biologics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fredleaf-biologics-inc-1677182)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky): 216 rows, by operating companies, filed since November 1, 2024, $10.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kentucky
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 145 GRAHAM AVE., ASTECC BUILDING - SUITE A159, Lexington, KY, 40506
- Phone: (205) 910-0641
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2015
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 504
- SEC identifier (CIK): 1677182

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 7, 2019 | New notice | $750,000 | $750,000 | $0 | 2 | Sep 6, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1677182/000167718219000004/0001677182-19-000004-index.htm) |
| Dec 19, 2016 | Amendment | $166,605 | $5 | $166,600 | 1 | Aug 11, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1677182/000167718216000003/0001677182-16-000003-index.htm) |
| Dec 5, 2016 | New notice | $24,000 | $5,000 | $19,000 | 1 | Aug 11, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1677182/000167718216000002/0001677182-16-000002-index.htm) |
| Jun 16, 2016 | New notice | $278,000 | $250,000 | $28,000 | 8 | Jun 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1677182/000167718216000001/0001677182-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Seth DeBolt | Executive Officer, Director |  |
| Chris Somerville | Director |  |
| William Baker | Director |  |
| Heather Youngs | Director |  |
| Jordan Wood | Executive Officer |  |

[Every Form D from the week of Nov 4, 2019](https://specstream.ai/data/form-d/week/2019-11-04) · [All recent filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RedLeaf Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).